Literature DB >> 17265061

Pharmacokinetics of tramadol is affected by MDR1 polymorphism C3435T.

Ondrej Slanar, Milan Nobilis, Jaroslav Kvétina, Olga Matousková, Jeffrey R Idle, Frantisek Perlík.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17265061     DOI： 10.1007/s00228-006-0255-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

1.  The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6.

Authors:  Thomas P Enggaard; Lars Poulsen; Lars Arendt-Nielsen; Kim Brøsen; Joachim Ossig; Søren H Sindrup
Journal:  Anesth Analg       Date:  2006-01       Impact factor: 5.108

2.  Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population.

Authors:  GuoXiang Wang; Hui Zhang; FeiFang He; XiangMing Fang
Journal:  Eur J Clin Pharmacol       Date:  2006-09-08       Impact factor: 2.953

3.  Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers.

Authors:  Rasmus Steen Pedersen; Per Damkier; Kim Brøsen
Journal:  Eur J Clin Pharmacol       Date:  2006-06-09       Impact factor: 2.953

4.  The hypoalgesic effect of tramadol in relation to CYP2D6.

Authors:  L Poulsen; L Arendt-Nielsen; K Brøsen; S H Sindrup
Journal:  Clin Pharmacol Ther       Date:  1996-12       Impact factor: 6.875

5.  Debilitating reaction following the initial dose of tramadol.

Authors:  P P Gleason; R F Frye; T O'Toole
Journal:  Ann Pharmacother       Date:  1997-10       Impact factor: 3.154

6.  Metabolism of the analgesic drug ULTRAM (tramadol hydrochloride) in humans: API-MS and MS/MS characterization of metabolites.

Authors:  W N Wu; L A McKown; S Liao
Journal:  Xenobiotica       Date:  2002-05       Impact factor: 1.908
  6 in total
  6 in total

Review 1.  Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.

Authors:  Robert Gharavi; William Hedrich; Hongbing Wang; Hazem E Hassan
Journal:  Pharm Res       Date:  2015-05-14       Impact factor: 4.200

2.  PharmGKB summary: tramadol pathway.

Authors:  Li Gong; Ulrike M Stamer; Mladen V Tzvetkov; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-07       Impact factor: 2.089

Review 3.  The Pharmacogenetics of Tramadol.

Authors:  Dorte Lassen; Per Damkier; Kim Brøsen
Journal:  Clin Pharmacokinet       Date:  2015-08       Impact factor: 6.447

Review 4.  Pharmacogenetics of chronic pain and its treatment.

Authors:  Svatopluk Světlík; Karolína Hronová; Hana Bakhouche; Olga Matoušková; Ondřej Slanař
Journal:  Mediators Inflamm       Date:  2013-05-20       Impact factor: 4.711

Review 5.  Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain.

Authors:  Catarina Chaves; Fernando Remiao; Salvatore Cisternino; Xavier Decleves
Journal:  Curr Neuropharmacol       Date:  2017-11-14       Impact factor: 7.363

6.  Evaluation of the Effect of CYP2D6 Genotypes on Tramadol and O-Desmethyltramadol Pharmacokinetic Profiles in a Korean Population Using Physiologically-Based Pharmacokinetic Modeling.

Authors:  Hyeon-Cheol Jeong; Soo Hyeon Bae; Jung-Woo Bae; Sooyeun Lee; Anhye Kim; Yoojeong Jang; Kwang-Hee Shin
Journal:  Pharmaceutics       Date:  2019-11-17       Impact factor: 6.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.